Literature DB >> 12388915

Pre-degenerated peripheral nerve extracts applied to the proximal stump of transected sciatic nerve enhance both regeneration and autotomic behavior in rats.

Joanna Lewin-Kowalik1, Wiesław Marcol, Magdalena Larysz-Brysz, Katarzyna Wolwender, Marita Pietrucha-Dutczak, Dariusz Górka.   

Abstract

BACKGROUND: Peripheral nerve regeneration after traumatic injury and standard repair with a nerve autograft is often incomplete and results in neuropathic pain. Peripheral nerve extracts applied to the proximal nerve stump by means of autologous, dead-ended connective tissue chambers (deCTC) are known to accelerate the rate of axon regeneration. This study tested if such extracts would influence autotomy, which is a behavioral measure of neuropathic pain in animal models. MATERIAL/
METHODS: The study was performed on Wistar rats. DeCTCs, filled with postmicrosomal fraction obtained from 7-day-predegenerated nerves (7D group) or fibrin (F group), were implanted into transected sciatic nerve. In the control group (C), sciatic nerve was transected and its distal part was removed. The self-mutilation behavior in rats was assessed daily for seven weeks after sciatic nerve transection. The onset as well as intensity of autotomy was measured. The progress of regeneration was assessed under light microscopy and histochemistry.
RESULTS: The earliest onset and greatest severity of autotomy were found in the 7D group. Regeneration progress was also highest in this group. In the F group, we found weaker regeneration and less autotomy. The control group showed no regeneration, but more autotomy than the F group.
CONCLUSIONS: Intensified autotomy may be the price paid for enhanced peripheral nerve regeneration after application of growth-promoting substances.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12388915

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  1 in total

1.  BDNF contributes to animal model neuropathic pain after peripheral nerve transection.

Authors:  Wiesław Marcol; Katarzyna Kotulska; Magdalena Larysz-Brysz; Joanna Lewin Kowalik
Journal:  Neurosurg Rev       Date:  2007-05-26       Impact factor: 2.800

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.